UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042896
Receipt number R000048965
Scientific Title A single-center analysis of 71 patients with thymic carcinoma
Date of disclosure of the study information 2021/02/01
Last modified on 2021/07/09 08:35:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single-center analysis of 71 patients with thymic carcinoma

Acronym

A single-center analysis of thymic carcinoma

Scientific Title

A single-center analysis of 71 patients with thymic carcinoma

Scientific Title:Acronym

A single-center analysis of thymic carcinoma

Region

Japan


Condition

Condition

Thymic carcinoma

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

A total of 71 patients underwent treatment for thymic carcinoma between January 1983 and January 2020 at Nagoya City University Hospital. The clinical and pathologic data of these patients are retrospectively reviewed to investigate the outcome and prognosis.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Outcome and prognosis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

A total of 71 patients underwent treatment for thymic carcinoma between January 1983 and January 2020 at Nagoya City University Hospital.

Key exclusion criteria

none

Target sample size

71


Research contact person

Name of lead principal investigator

1st name Keisuke
Middle name
Last name Yokota

Organization

Nagoya City University

Division name

Department of Oncology, Immunology and Surgery

Zip code

467-8601

Address

1, Kawasumi Mizuho-cho, Mizuho-ku, Nagoya, Aichi

TEL

052-853-8231

Email

keyokota@med.nagoya-cu.ac.jp


Public contact

Name of contact person

1st name Keisuke
Middle name
Last name Yokota

Organization

Nagoya City University

Division name

Department of Oncology, Immunology and Surgery

Zip code

467-8601

Address

1, Kawasumi Mizuho-cho, Mizuho-ku, Nagoya, Aichi

TEL

052-853-8231

Homepage URL


Email

keyokota@med.nagoya-cu.ac.jp


Sponsor or person

Institute

Nagoya City University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya City University

Address

1, Kawasumi Mizuho-cho, Mizuho-ku, Nagoya, Aichi

Tel

052-853-8231

Email

keyokota@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

71

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 12 Month 08 Day

Date of IRB

2020 Year 12 Month 08 Day

Anticipated trial start date

2020 Year 12 Month 08 Day

Last follow-up date

2021 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2021 Year 06 Month 01 Day


Other

Other related information

none


Management information

Registered date

2021 Year 01 Month 04 Day

Last modified on

2021 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048965


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name